Pharmaceutical and Medical Device Act in Japan was amended in 2019, making barcode labeling mandatory to improve traceability of medicines. In addition, the package inserts have been digitized to ensure that the information is always up-to-date, and the GS1 barcodes and GTINs (Global Trade Item Number) are now used to access this digitized information. However, at present, GS1 barcodes are not widely used to improve patient safety and operational efficiency in hospitals, with the exception of some advanced medical institutions. To put this situation in the right direction, a grand design is needed that includes all stakeholders involved in medical materials, rather than local optimization. In Japan, medical products have been already coded and barcode labeled according to international standards. Discussing the data utilization accumulated through the use of these barcodes from various angles and positions and reviewing the current issues and problems is extremely important as a compass for advancing medical DX beyond the identification of objects. In this session, we will discuss the challenges and prospects regarding the effective and efficient use of standard codes from various standpoints, including the manufacture, utilization and regulation of medical materials.